Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (358)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ORMEROD, I. E. C.
Right arrow Articles by ZILKHA, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ORMEROD, I. E. C.
Right arrow Articles by ZILKHA, K. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 110, No. 6, 1579-1616, 1987
© 1987 Guarantors of Brain


research-article

THE ROLE OF NMR IMAGING IN THE ASSESSMENT OF MULTIPLE SCLEROSIS AND ISOLATED NEUROLOGICAL LESIONS

A QUANTITATIVE STUDY

I. E. C. ORMEROD, D. H. MILLER, W. I. McDONALD, E. P. G. H. DU BOULAY, P. RUDGE, B. E. KENDALL, I. F. MOSELEY, G. JOHNSON, P. S. TOFTS, A. M. HALLIDAY, A. M. BRONSTEIN, F. SCARAVILLI, A. E. HARDING, D. BARNES and K. J. ZILKHA

Institute of Neurology and The National Hospitals, Queen Square London

Correspondence to: Professor W. I. McDonald, Institute of Neurology, Queen Square, London WCIN 3BG.

The form and distribution of MRI abnormalities in 114 patients with clinically definite multiple sclerosis (MS) have been compared with observations on 53 apparently healthy individuals, 129 patients with isolated focal neurological lesions with which MS often presents (51 patients with optic neuritis, 44 with isolated brainstem lesions and 34 with isolated spinal cord syndromes) and 105 patients with disorders which may be confused clinically or radiologically with MS. The latter comprised 55 patients with cerebral vascular disease (including 7 cases of dementia with diffuse white matter disease), 24 with degenerative ataxic disorders, 8 with cerebellar tonsillar ectopia, 7 with sarcoidosis and 11 with a variety of other disorders.

Periventricular abnormalities were found in all but 2 patients with MS and discrete white matter lesions in all but 12. Characteristically the periventricular changes in MS were irregular in outline. Periventricular abnormalities which were often milder and of smooth outline were seen in 37/55 patients with cerebral vascular disease, 9/24 with cerebellar degeneration, 5/7 with sarcoidosis and in 2/3 apparently healthy individuals over the age of 60. The appearances in the 7 cases of dementia resembled those with advanced MS.

Cerebellar and/or brainstem atrophy characteristic of the cerebellar degenerations, in the absence of white matter abnormalities, was helpful in making the distinction from MS. Congenital anomalies and tumours in the region of the brainstem and foramen magnum were readily shown.

More than half the patients with symptoms attributable to isolated focal neurological lesions had additional lesions at presentation. MS cannot be diagnosed in these cases at presentation, but repeat scans after 5 to 20 months in 25 patients with optic neuritis and 10 with clinically isolated brainstem lesions have shown new lesions in 7 (20%). The patients with new lesions fulfil the criteria for clinically probable MS (Poser et al., 1983).

Measurements of T1, and T2 in vivo permitted the distinction of acute from chronic brainstem lesions. There were quantitative differences in T1, and T2 between the normal appearing white matter in MS and normal brain. Studies of postmortem brains provided convincing evidence that the MRI abnormalities in MS correspond with plaques. Evidence is adduced to support the view that an important source of the abnormal NMR signals in acute lesions is oedema, and in chronic lesions is gliosis; demyelination per se is unlikely to make an important contribution.

Received December 23, 1986. Revised March 4, 1987. Accepted March 12, 1987.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
O. Garcea, A. Villa, F. Caceres, T. Adoni, M. Alegria, R. Barbosa Thomaz, R. Buzo, L. Llamas Lopez, and M. Rivera Kindel
Early treatment of multiple sclerosis: a Latin American Experts Meeting
Multiple Sclerosis, October 1, 2009; 15(3_suppl): S1 - S12.
[Abstract] [PDF]


Home page
BrainHome page
Y. He, A. Dagher, Z. Chen, A. Charil, A. Zijdenbos, K. Worsley, and A. Evans
Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load
Brain, May 12, 2009; (2009) awp089v1.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al.
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174.
[Abstract] [PDF]


Home page
Am. J. Roentgenol.Home page
N. Venkatanarasimha, W. Mukonoweshuro, and J. Jones
AJR Teaching File: Symmetric Demyelination
Am. J. Roentgenol., September 1, 2008; 191(3_Supplement): S34 - S36.
[Full Text] [PDF]


Home page
NeurologyHome page
S. Mesaros, M. A. Rocca, M. Absinta, A. Ghezzi, N. Milani, L. Moiola, P. Veggiotti, G. Comi, and M. Filippi
Evidence of thalamic gray matter loss in pediatric multiple sclerosis
Neurology, March 25, 2008; 70(13_Part_2): 1107 - 1112.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain, March 1, 2008; 131(3): 808 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
S. C. Fossey, C. L. Vnencak-Jones, N. J. Olsen, S. Sriram, G. Garrison, X. Deng, P. S. Crooke III, and T. M. Aune
Identification of Molecular Biomarkers for Multiple Sclerosis
J. Mol. Diagn., April 1, 2007; 9(2): 197 - 204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. Pagani, R. Bammer, M.A. Horsfield, M. Rovaris, A. Gass, O. Ciccarelli, and M. Filippi
Diffusion MR Imaging in Multiple Sclerosis: Technical Aspects and Challenges
AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 411 - 420.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al.
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Arch Neurol, April 1, 2006; 63(4): 614 - 619.
[Full Text] [PDF]


Home page
Arch NeurolHome page
E. M. Frohman, O. Stuve, E. Havrdova, J. Corboy, A. Achiron, R. Zivadinov, P. S. Sorensen, J. T. Phillips, B. Weinshenker, K. Hawker, et al.
Therapeutic Considerations for Disease Progression in Multiple Sclerosis: Evidence, Experience, and Future Expectations
Arch Neurol, October 1, 2005; 62(10): 1519 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Gallo, M. Rovaris, R. Riva, A. Ghezzi, B. Benedetti, V. Martinelli, A. Falini, G. Comi, and M. Filippi
Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis
Arch Neurol, May 1, 2005; 62(5): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Iliceto, and C. Sborgia
Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1264 - 1268.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
G R W. Moore
MRI Correlates of MS Pathologic Subtypes
Multiple Sclerosis, February 1, 2005; 11(1): 103 - 105.
[PDF]


Home page
Mult SclerHome page
L M. Grimaldi, A Pincherle, F Martinelli-Boneschi, M Filippi, F Patti, A Reggio, D Franciotta, L Allegra, G Comi, and F Blasi
An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients
Multiple Sclerosis, October 1, 2003; 9(5): 467 - 471.
[Abstract] [PDF]


Home page
NeurologyHome page
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al.
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 9, 2003; 61(5): 602 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M R Piras, I Magnano, E D G Canu, K S Paulus, W M Satta, A Soddu, M Conti, A Achene, G Solinas, and I Aiello
Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 878 - 885.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom
Predicting multiple sclerosis at optic neuritis onset
Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141.
[Abstract] [PDF]


Home page
Mult SclerHome page
H. McFarland, F. Barkhof, J. Antel, and D. Miller
The role of MRI as a surrogate outcome measure in multiple sclerosis
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 40 - 51.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58.
[Abstract] [PDF]


Home page
Mult SclerHome page
P Kapeller, P A Brex, D Chard, C Dalton, C M Griffin, M A McLean, G J. Parker, A J Thompson, and D H Miller
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis
Multiple Sclerosis, June 1, 2002; 8(3): 207 - 210.
[Abstract] [PDF]


Home page
Mult SclerHome page
C M Griffin, J Dehmeshki, D T Chard, G J. Parker, G J Barker, A J Thompson, and D H Miller
T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis
Multiple Sclerosis, June 1, 2002; 8(3): 211 - 216.
[Abstract] [PDF]


Home page
Mult SclerHome page
H F McFarland, F Barkhof, J Antel, and D H Miller
The role of MRI as a surrogate outcome measure in multiple sclerosis
Multiple Sclerosis, February 1, 2002; 8(1): 40 - 51.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Palace
MAKING THE DIAGNOSIS OF MULTIPLE SCLEROSIS
J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(suppl_2): ii3 - ii8.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F Patti, M L Cataldi, F Nicoletti, E Reggio, A Nicoletti, and A Reggio
Combination of cyclophosphamide and interferon-{beta} halts progression in patients with rapidly transitional multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J.L. Hynson, A.J. Kornberg, L.T. Coleman, L. Shield, A.S. Harvey, and M.J. Kean
Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children
Neurology, May 22, 2001; 56(10): 1308 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P. A. Brex, S. M. Leary, G. T. Plant, A. J. Thompson, and D. H. Miller
Magnetization Transfer Imaging in Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 947 - 951.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P A Brex, K A Miszkiel, J I O'Riordan, G T Plant, I F Moseley, A J Thompson, and D H Miller
Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI
J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 390 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. Rovaris, M. Bozzali, G. Santuccio, G. Iannucci, M. P. Sormani, B. Colombo, G. Comi, and M. Filippi
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis
J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 723 - 727.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. C. Dale, C. de Sousa, W. K. Chong, T. C. S. Cox, B. Harding, and B. G. R. Neville
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children
Brain, December 1, 2000; 123(12): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. R. W. Moore, E. Leung, A. L. MacKay, I. M. Vavasour, K. P. Whittall, K. S. Cover, D. K. B. Li, S. A. Hashimoto, J. Oger, T. J. Sprinkle, et al.
A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain
Neurology, November 28, 2000; 55(10): 1506 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C M Griffin, G J. Parker, G J Barker, A J Thompson, and D H Miller
MTR and T1 provide complementary information in MS NAWM, but not in lesions
Multiple Sclerosis, October 1, 2000; 6(5): 327 - 331.
[Abstract] [PDF]


Home page
NEJMHome page
L. D. Jacobs, R. W. Beck, J. H. Simon, R. P. Kinkel, C. M. Brownscheidle, T. J. Murray, N. A. Simonian, P. J. Slasor, A. W. Sandrock, and The CHAMPS Study Group
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
N. Engl. J. Med., September 28, 2000; 343(13): 898 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L. Leocani, T. Locatelli, V. Martinelli, M. Rovaris, M. Falautano, M. Filippi, G. Magnani, and G. Comi
Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings
J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 192 - 198.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. A. Caruana, M. B. Davies, S. J. M. Weatherby, R. Williams, N. Haq, D. H. Foster, and C. P. Hawkins
Correlation of MRI lesions with visual psychophysical deficit in secondary progressive multiple sclerosis
Brain, July 1, 2000; 123(7): 1471 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
M. Rovaris, M. Filippi, L. Minicucci, G. Iannucci, G. Santuccio, F. Possa and, and G. Comi
Cortical/Subcortical Disease Burden and Cognitive Impairment in Patients with Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2000; 21(2): 402 - 408.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
A. Rovira, J. Alonso, G. Cucurella, C. Nos, M. Tintoré, S. Pedraza, J. Rio, and X. Montalban
Evolution of Multiple Sclerosis Lesions on Serial Contrast-Enhanced T1-Weighted and Magnetization-Transfer MR Images
AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1939 - 1945.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
D. M. Moriarty, A. J. Blackshaw, P. R. Talbot, H. L. Griffiths, J. S. Snowden, V. F. Hillier, S. Capener, R. D. Laitt, and A. Jackson
Memory Dysfunction in Multiple Sclerosis Corresponds to Juxtacortical Lesion Load on Fast Fluid-Attenuated Inversion-Recovery MR Images
AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1956 - 1962.
[Abstract] [Full Text]


Home page
NeurologyHome page
P. A. Brex, J. I. O'Riordan, K. A. Miszkiel, I. F. Moseley, A. J. Thompson, G. T. Plant, and D. H. Miller
Multisequence MRI in clinically isolated syndromes and the early development of MS
Neurology, October 1, 1999; 53(6): 1184 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
W I McDonald
Physicians, subsequence and consequence
J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 282 - 289.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
I. Nakashima, K. Fujihara, N. Okita, S. Takase, and Y. Itoyama
Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 153 - 157.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Tourbah, O. Gout, R. Liblau, O. Lyon-Caen, C. Bougniot, M. T. Iba-Zizen, and E. A. Cabanis
Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS?
Neurology, July 1, 1999; 53(2): 396 - 396.
[Abstract] [Full Text]


Home page
BrainHome page
P. Sarchielli, O. Presciutti, G. P. Pelliccioli, R. Tarducci, G. Gobbi, P. Chiarini, A. Alberti, F. Vicinanza, and V. Gallai
Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients
Brain, March 1, 1999; 122(3): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Miki, R. I. Grossman, J. K. Udupa, M. A. van Buchem, L. Wei, M. D. Phillips, U. Patel, J. C. McGowan, and D. L. Kolson
Differences between Relapsing-Remitting and Chronic Progressive Multiple Sclerosis as Determined with Quantitative MR Imaging
Radiology, March 1, 1999; 210(3): 769 - 774.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
Neurology, February 1, 1999; 52(3): 599 - 599.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
S. J. Khoury and H. L. Weiner
Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies?
Arch Intern Med, March 23, 1998; 158(6): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P Sarchielli, O Presciutti, R Tarducci, G Gobbi, A Alberti, G P Pelliccioli, A Orlacchio, and V Gallai
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta -1a: results of a preliminary study
J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K. P Ebmeier, N. Prentice, A. Ryman, E. Halloran, J E. Rimmington, J. K K Best, and G. M Goodwin
Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging
J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F. Thomke, E. Lensch, K. Ringel, and H. C. Hopf
Isolated cranial nerve palsies in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 682 - 685.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Hutchinson, T Burke, and M Hutchinson
Neuropsychological assessment in multiple sclerosis: methodological issues and concerns
Multiple Sclerosis, September 1, 1996; 2(2): 57 - 65.
[Abstract] [PDF]


Home page
Mult SclerHome page
D. Miller
Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force
Multiple Sclerosis, June 1, 1996; 1(6): 335 - 338.
[Abstract] [PDF]


Home page
Arch OphthalmolHome page
J. L. Keltner, C. A. Johnson, J. O. Spurr, R. W. Beck, and Optic Neuritis Study Group
Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial
Arch Ophthalmol, July 1, 1994; 112(7): 946 - 953.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. E. Goodkin, R. A. Rudick, and J. S. Ross
The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol, May 1, 1994; 51(5): 505 - 516.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Pelletier, M. Habib, O. Lyon-Caen, G. Salamon, M. Poncet, and R. Khalil
Functional and Magnetic Resonance Imaging Correlates of Callosal Involvement in Multiple Sclerosis
Arch Neurol, October 1, 1993; 50(10): 1077 - 1082.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. W. Beck, J. Arrington, F. R. Murtagh, P. A. Cleary, D. I. Kaufman, and Optic Neuritis Study Group
Brain Magnetic Resonance Imaging in Acute Optic Neuritis: Experience of the Optic Neuritis Study Group
Arch Neurol, August 1, 1993; 50(8): 841 - 846.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
D. W. Paty, R. A. Koopmans, GuoJun Zhao, D. K.B. Li, J. J.F. Oger, and J. Petkau
Magnetic Resonance Imaging (MRI) As an Outcome Measure in Multiple Sclerosis
Neurorehabil Neural Repair, January 1, 1993; 7(3-4): 117 - 129.
[PDF]


Home page
Arch NeurolHome page
R. Capra, N. Marciano, L. A. Vignolo, A. Chiesa, and R. Gasparotti
Gadolinium--Pentetic Acid Magnetic Resonance Imaging in Patients With Relapsing Remitting Multiple Sclerosis
Arch Neurol, July 1, 1992; 49(7): 687 - 689.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. I. Chimowitz, M. L. Estes, A. J. Furlan, and I. A. Awad
Further Observations on the Pathology of Subcortical Lesions Identified on Magnetic Resonance Imaging
Arch Neurol, July 1, 1992; 49(7): 747 - 752.
[Abstract] [PDF]


Home page
J Child NeurolHome page
W. A. Marks, R. M. Shuman, and J. B. Bodensteiner
HLA Patterns in Children With Parainflammatory Leukoencephalomyelitis
J Child Neurol, April 1, 1991; 6(2): 150 - 154.
[Abstract] [PDF]


Home page
J Child NeurolHome page
S. D. Johnsen, A. D. Sidell, and C. R. Bird
Subtle Encephalomyelitis in Children: A Variant of Acute Disseminated Encephalomyelitis
J Child Neurol, July 1, 1989; 4(3): 214 - 217.
[Abstract] [PDF]


Home page
Arch NeurolHome page
F. A. J. Muller, P. E. Hanny, W. Wichmann, W. Fierz, and M. R. Dursteler
Cerebrospinal Fluid Immunoglobulins and Multiple Sclerosis: Correspondence With Magnetic Resonance Imaging and Visually Evoked Potential Changes
Arch Neurol, April 1, 1989; 46(4): 367 - 371.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. S. Younger, S. Chou, A. P. Hays, D. J. Lange, R. Emerson, M. Brin, H. Thompson Jr, and L. P. Rowland
Primary Lateral Sclerosis: A Clinical Diagnosis Reemerges
Arch Neurol, December 1, 1988; 45(12): 1304 - 1307.
[Abstract] [PDF]


Home page
J Child NeurolHome page
W. A. Marks, J. B. Bodensteiner, G. B. Bobele, M. Hamza, and D. A. Wilson
Parainflammator Leukoencephalomyelitis: Clinical and Magnetic Resonance Imaging Findings
J Child Neurol, July 1, 1988; 3(3): 205 - 213.
[Abstract] [PDF]


Home page
RadiologyHome page
J. C. J. Bot, F. Barkhof, G. L. a Nijeholt, D. van Schaardenburg, A. E. Voskuyl, H. J. Ader, J. A. L. Pijnenburg, C. H. Polman, B. M. J. Uitdehaag, E. G. J. Vermeulen, et al.
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology, April 1, 2002; 223(1): 46 - 56.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.